On Monday, December 13, Nadine Beauger, IRICoR’s President and CEO, took part in the panel discussion: Leveraging our niches of excellence, along with Stéphane Létourneau, Executive Vice President at Mila, and Stéphane Paquet, President and CEO at Montréal International. This panel was presented as part of the Strategic Forum: The pharmaceutical industry: At the forefront of life sciences, an initiative of the Board of The Chamber of Commerce of Metropolitan Montreal (CCMM).
The event was an opportunity for Nadine to emphasize the importance of collaboration and knowledge sharing within the life sciences industry:
“For the future, I hope that there will be an optimal integration of all levels, from fundamental research to therapeutic applications, and that we will become a hub across Quebec and Canada in the coming years.” – Nadine Beauger
The Minister of Economy and Innovation, Pierre Fitzgibbon, launched this long-awaited meeting with a key announcement: the allocation through the Fonds d’accélération des collaborations en santé of $13.85 million to the Institut de Pharmacologie de Sherbrooke (IPS) of the Université de Sherbrooke for the Acuité- Québec Consortium project. With funding of $27M over three years in total, thanks to the commitment made by many industrial and academic partners, including IRICoR, this large-scale initiative aims to better predict the action of drugs developed in the laboratory through cutting-edge processes based on artificial intelligence and molecular imaging.
The CCMM Strategic Forum brought together some 20 high-level stakeholders from the life sciences and health technologies sector to discuss, among other things, the innovation opportunities created by the pandemic.
